Olivo Pimentel, Veronica
Marcus, Damiënne
van der Wiel, Alexander MA
Lieuwes, Natasja G
Biemans, Rianne
Lieverse, Relinde IY http://orcid.org/0000-0002-2841-5334
Neri, Dario
Theys, Jan
Yaromina, Ala
Dubois, Ludwig J http://orcid.org/0000-0002-8887-4137
Lambin, Philippe
Clinical trials referenced in this document:
Documents that mention this clinical trial
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
https://doi.org/10.1136/jitc-2020-001764
Documents that mention this clinical trial
Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy
https://doi.org/10.1136/jitc-2020-001764
Funding for this research was provided by:
H2020 European Research Council (ERC-ADG-2015, 694812, Hypoximmuno)
MSCA-ITN (Radiate, 642623)
H2020 European Program (H2020-2015-17, 733008, ImmunoSABR)